contrast 4, 15 and epidural anesthesia, 40 traumatic arachnoiditis, 17, 22, 25, 38 arachnoiditis from subarachnoid hemorrhage, 3, 23, 39 congenital arachnoid malformations, 6, 19, 28, 32, 35 and traumatic 17, 37, 41 and idiopathic arachnoid cysts. 1, 7, 13, 14, 16, 21, 26, 30, 34, 36, 42 Treatment, including nonsurgical and surgical management strategies, has provided mixed results, and follow-up offered in the medical literature has been poor. 22, 23, 25, 33 This report describes our experience with thoracic arachnoid pathology, including our series of patients with thoracic spinal cord herniation that has been previously described. 2 
Methods
This is a retrospective study of cases involving patients with thoracic myelopathy due to arachnoid pathology managed during the years 1995-2012. All patients were followed up at 6-month and (when stable) 12-month intervals, and all surgical patients were operated on by the senior author (M.N.H.). The study was approved by the institutional review board of the University of Alabama at Birmingham.
Preoperative, 1-year postoperative, and contemporary last follow-up scores on the modified Japanese Orthopaedic Association (mJOA) scale, 6 excluding upper-extremity assessment, were recorded for all patients. Data are expressed as mean and standard deviation, or frequency and percentage, whenever appropriate. Analyses included descriptive statistics and paired t-tests with Bonferroni correction. Given the small sample size, a Wilcoxon signed-rank test was performed to verify the results.
Results
Twenty-eight cases of thoracic arachnoid pathology were identified. Fifteen patients (54%) were male and 13 (44%) were female; the patients' mean age was 46.5 years. Their average mJOA score (without upper-extremity assessment) at presentation was 6.25. The mean duration of clinical follow-up for all patients was 5.8 years after initial consultation (range 1-15 years). Myelopathy, gait dysfunction, paraparesis, and pain were the most common presenting signs and symptoms. The pathology was focal (short-segment; within 2 vertebral segments) in 12 patients (43%) and diffuse (long-segment; beyond 2 vertebral segments) in 16 (57%). Ventral and dorsal arachnoid bands were the most common type of pathology, and 25 patients underwent surgical treatment. Table 1 describes the characteristics of patients included in this series.
Characteristics of Patients Whose Condition Improved With Surgery
Patients whose condition (as assessed at 1 year and at last follow-up) improved with surgery compared with those of patients whose condition remained stable or deteriorated postoperatively are shown in Table 2 . Due to the small number of cases, statistical analysis was of limited utility. To address this limitation, the cases were analyzed according to the extent of thoracic cord involvement.
Short-segment pathology was defined as focal pathology within, but not beyond, 2 thoracic vertebral segments, and long-segment pathology was defined as pathology extending beyond 2 thoracic vertebral segments.
Effects of Extent of Thoracic Cord Involvement on Outcome
The short-segment and long-segment pathology groups are compared in Table 3 . They differed in sex (p = 0.05), number of patients with ventral or dorsal arachnoid bands (p = 0.003), number of patients who underwent reoperation (p = 0.02), and operations per surgically treated patient (p = 0.04). Signal change in the cord on MRI without definitive syrinx was more common in patients with short-segment disease (p = 0.02), whereas patients with long-segment disease more frequently presented with a syrinx (p = 0.02).
While not universal, improvement in mJOA scores was seen at 1 year (p = 0.0001) and at last follow-up (p = 0.04) in this case series (Table 4 ). Surgically treated patients in both the short-and long-segment pathology groups demonstrated improvement at 1 year (p = 0.049 and 0.0004, respectively). Patients with short-segment pathology who underwent a single operative intervention had improvement in mJOA scores at 1 year (p = 0.002) and at last follow-up (p = 0.002). Patients with long-segment pathology who had multiple operative interventions had improvement in mJOA at 1 year (p = 0.004) and at last follow-up (p = 0.14), but the improvement at last follow-up in this group did not reach statistical significance (Table 5) . (12 Patients) . Ten patients were treated initially with detethering procedures ( Table  6) . Seven of these patients who underwent initial detethering did well in the long term. Three patients received additional detethering procedures ( Table 7) . One of these 3 patients had lasting benefit (Case 3), the other 2 did not. When assessing outcomes by initial pathology, 5 of 6 patients with ventral or dorsal arachnoid bands did well (Cases 2-5 and 7). While 1 patient with an arachnoid duplication cyst (Case 1; Fig. 1 ) and another with a posttraumatic arachnoid cyst (Case 6) improved long-term, 1 patient with posttraumatic tethering (Case 8) remained stable. The 2 patients with poor long-term results had recurrent scarring and retethering with progressive worsening of symptoms despite additional attempts to treat with detethering (Case 11) or CSF diversion (Case 12). The latter patient's condition was made worse by an attempt to shunt what was misinterpreted as a syrinx but was actually signal change in the spinal cord at an outside facility, and ultimately by the senior author's (M.N.H.) third attempt at detethering. (16 Patients) . Of the 15 surgically treated patients with long-segment pathology (Table 8 ), 7 (47%) underwent initial detethering procedures without shunt placement and 8 (53%) were treated with detethering and syringopleural CSF diversion as an initial treatment. Of the 7 patients initially treated with detethering without shunt placement, all eventually required CSF diversion of recurrent loculations due to scarring or new syrinx formation (Table 9) . Of the 8 patients who had a syringopleural shunt placed as an initial procedure in addition to detethering, 3 patients did well in the long term without need of a secondary procedure (Cases 5, 9, and 10). Three others improved with initial CSF diversion but have required shunt revision (Cases 4, 6, and 8). One patient was stable at 1 year but had progressive loss at late follow-up without new treatable pathology (Case 15), and the eighth patient's condition was worse despite shunt revision for recurrent syrinx (Case 12). Fifteen of the 25 surgicallly treated patients in this series required spinal CSF diversion procedures (60%). All were patients with long-segment pathology. Of the 15 patients treated with CSF diversion, 8 (53%) presented with a syrinx and were treated at the initial procedure with a syringopleural shunt as noted above.
Short-Segment Pathology

Long-Segment Pathology
Comparing outcomes by initial pathology, 3 of 4 patients with posttraumatic arachnoid tethering and syrinx did well. Three of 4 patients with arachnoid duplication cysts demonstrated improvement. All experienced reexpansion of the original cyst requiring placement of a cystopleural shunt as secondary procedure. One patient (Case 6) with multiple postsurgical arachnoid bands and tethering with a syrinx did well in the long term, but required revision of her syringopleural shunt as a secondary procedure. Neither of the 2 patients with posthemorrhagic arachnoid scarring and arachnoid loculations did well, despite multiple attempts at detethering and CSF diversion of recurrent arachnoid loculations (Cases 13 and 14) .
Illustrative Cases
Short-Segment Case 7: Ventral Spinal Cord Tether.
A 62-year-old male presented with neck pain, upper extremity dysesthesias (right greater than left), and thoracic myelopathy with gait disturbance and a T-3 sensory level (initial mJOA 7). Imaging revealed ventral tethering due to arachnoid bands at T-3 ( Fig. 2A-C) . We initially believed this patient had a ventral cord herniation. He underwent T2-5 laminectomy to detether his spinal cord ventrally. After sectioning of the dentate ligaments no ventral dural duplication or defect was identified. At 1-year and 5-year follow-up, the patient's myelopathy had improved as had his trunk sensation and bladder function (follow-up mJOA 9). He complained of persistent sensory changes in both legs. MRI studies at both of these follow-up examinations demonstrated decompression of the spinal cord and elimination of the preoperative ventral tethering ( Fig. 2D and E) .
Long-Segment Case 1: Arachnoid Duplication Cyst.
A 40-year-old man presented with thoracic paraparesis and myelopathy (initial mJOA 6). Imaging revealed a T5-10 intradural lesion suspicious for an arachnoid duplication cyst, which was confirmed during operative exploration ( Fig. 3A and B) . Laminectomy of T5-10 was performed with excision of the cyst. The perceived arachnoid communication with the cyst was ligated with a suture. The patient's condition improved following cyst excision. Eight weeks later, however, he had recurrent symptoms of thoracic paraparesis and myelopathy. Imaging revealed an extraarachnoid reaccumulation of CSF in the cyst resection site with cord compression. A cystopleural shunt was placed, eliminating the extraarachnoid accumulation of CSF. The shunt required multiple revisions secondary to low pressure/overshunting headaches. At the 8-year follow-up visit, the patient was fully functional and did not have headaches. On examination he had residual increased tone in the left lower extremity, but he remained functional and employed by a major information packaging, distribution, and delivery corporation (long-term mJOA 9). At 12 years' follow-up his examination findings were stable and he had retired from his job. MR images obtained at 8-and 12-year follow-up ( Fig. 3C and D) reveal collapse of the extra arachnoid cyst with no evidence of cord compression.
Discussion
The management of thoracic myelopathy from pathology involving the arachnoid mater is challenging. Even though the pathological processes may be distinctly different, surgical treatment uniformly encompasses detethering of the cord, lysis of adhesions and bands, and CSF diversion for treatment of cystic loculations or syrinx formation.
We report our experience with the management of 28 cases of thoracic arachnoid pathology causing progressive myelopathy. Although the number of cases in this study is small, it appears that the majority of patients with this condition benefit from detethering surgery. We found that the extent of the thoracic cord compromise influences the disease course and outcome. Patients with diffuse, longsegment involvement frequently require repeated surgery and CSF diversion. Patients with short-segment pathology tend to improve after a single operation.
The causes of the different types of thoracic arachnoid pathology are numerous. Spontaneous thoracic spinal cord herniation has been attributed to remote trauma, repetitive hyperflexion and extension, dural erosion from arachnoid cyst, congenital defect, disc prolapse, and dural duplication. 2 Tethering of the spinal cord and arachnoid cyst formation have been associated with previous trauma. 1, 16, 18, 34, 37 Arachnoiditis has been found to occur as a result of infection (for example, tuberculosis and malarial infections of the meninges), 9, 10, 20, 24, 27 and after cranial aneurysmal subarachnoid hemorrhage, with blood settling in the spinal subarachnoid space and causing delayed arachnoiditis. 3, 13, 23, 39 Ionic intrathecal contrast administration is another known cause of thoracic and lumbar arachnoiditis. 15 Idiopathic causes of arachnoid adhesions, tethering, and scarring are rare but have been reported. 2, 12, 29 Arachnoid cysts and dural duplication are likely congenital and a consequence of failure of normal embryological development. A ventral arachnoid or dural band may be a remnant of the endomesenchymal tract, which is hypothesized to be part of the etiology of split cord malformation. 31 Congenital arachnoid cysts may develop in utero as a result of splitting or duplication of the arachnoid or from a defect in condensation of the mesenchyme. Arachnoid cysts are thought to form from a ball-valve mechanism of fluid through a congenital or traumatic arachnoid defect, an osmotic gradient between the intra-and extra-cystic space, or a malformation causing trapped fluid within the arachnoid membranes or to develop secondary to hypersecretive fluid production by cells in the cyst wall. 5 
Clinical Features
Patients with thoracic arachnoid pathology present with symptoms of myelopathy, gait disturbance, paraparesis, and with pain and urinary dysfunction, either acutely or in a delayed fashion. Symptoms may worsen over months to years, and a patient's examination findings may fluctuate with time.
Imaging Characteristics
Magnetic resonance imaging has been the most helpful modality for assessing thoracic spinal arachnoid pathology. MRI provides the means to assess spinal cord compression, syrinx formation, and the architecture of the arachnoid pathology. 11 In select cases, CT myelography has been useful to reinforce the MRI studies, revealing ventral tethering of the spinal cord, arachnoid cysts, duplication cysts, or cystic cavitations. 2 
Treatment
The management of thoracic myelopathy due to arachnoid pathology with tethering with or without arachnoid loculations and/or a syrinx can be difficult. We found that across a variety of thoracic arachnoid pathologies, short-segment thoracic cord compression or teth- ering spanning a short segment only often responds to microsurgical detethering as an initial procedure. Longsegment arachnoid pathology appears to respond poorly to microsurgical detethering without shunt placement and typically requires permanent CSF diversion of recurrent arachnoid loculations and/or syrinx to palliate symptom progression. Serial follow-up of these patients is critical, as retethering with new cyst or syrinx formation can occur, as can shunt failure.
Conclusions
A variety of arachnoid pathologies can cause thoracic cord compression and tethering with subsequent my- elopathy. Long-term follow-up in this, the largest series of cases of thoracic arachnoid pathology with the longest follow-up reported to date, suggests that patients with symptomatic thoracic arachnoid pathology benefit from surgical treatment. The extent of thoracic cord involvement appears to be an important predictor of the disease course and outcome. Our experience suggests that microsurgical detethering of short-segment arachnoid pathology is of value as an initial procedure. Patients with long-segment arachnoid pathology will develop recurrent scarring with cystic loculations or syrinx formation, necessitating a CSF diversion procedure. Our current strategy is to perform detethering in patients with short-segment thoracic arachnoid pathology and to place a shunt in cystic loculations or syrinx cavitations associated with long-segment arachnoid pathology as primary procedures. Utilizing a comprehensive follow-up strategy, we have provided benefit (improvement or stabilization) to approximately 75% of the patients we have surgically treated with this progressively debilitating pathology over a 17-year experience.
Optimal care of the patient with myelopathy from thoracic arachnoid pathology can be accomplished by determining the nature of the pathology, the extent of the pathology, the acuity of symptoms, the severity of neurological deficits, and imaging study characteristics. Serial long-term clinical and MRI follow-up of these patients is critical as delayed neurological deterioration following treatment, including late treatment failure, is common, particularly among patients with long-segment pathology. 
